Your browser doesn't support javascript.
loading
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis.
Guglielmelli, Paola; Pacilli, Annalisa; Rotunno, Giada; Rumi, Elisa; Rosti, Vittorio; Delaini, Federica; Maffioli, Margherita; Fanelli, Tiziana; Pancrazzi, Alessandro; Pietra, Daniela; Salmoiraghi, Silvia; Mannarelli, Carmela; Franci, Annalisa; Paoli, Chiara; Rambaldi, Alessandro; Passamonti, Francesco; Barosi, Giovanni; Barbui, Tiziano; Cazzola, Mario; Vannucchi, Alessandro M.
Afiliación
  • Guglielmelli P; Centro Ricerca e Innovazione delle Malattie Mieloproliferative (CRIMM), Azienda Ospedaliera-Universitaria Careggi, Firenze, Italy.
  • Pacilli A; Department of Experimental and Clinical Medicine, DENOTHE Centre, University of Florence, Florence, Italy.
  • Rotunno G; Centro Ricerca e Innovazione delle Malattie Mieloproliferative (CRIMM), Azienda Ospedaliera-Universitaria Careggi, Firenze, Italy.
  • Rumi E; Department of Experimental and Clinical Medicine, DENOTHE Centre, University of Florence, Florence, Italy.
  • Rosti V; Centro Ricerca e Innovazione delle Malattie Mieloproliferative (CRIMM), Azienda Ospedaliera-Universitaria Careggi, Firenze, Italy.
  • Delaini F; Department of Experimental and Clinical Medicine, DENOTHE Centre, University of Florence, Florence, Italy.
  • Maffioli M; Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.
  • Fanelli T; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Pancrazzi A; Center for the Study of Myelofibrosis, Biotechnology Research Area, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.
  • Pietra D; Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
  • Salmoiraghi S; Division of Hematology, Department of Specialistic Medicine, Ospedale Azienda Socio Sanitaria Territoriale (ASST)-Sette Laghi, Varese, Italy.
  • Mannarelli C; Department of Experimental and Clinical Medicine, University of Insubria, Varese, Italy.
  • Franci A; Centro Ricerca e Innovazione delle Malattie Mieloproliferative (CRIMM), Azienda Ospedaliera-Universitaria Careggi, Firenze, Italy.
  • Paoli C; Department of Experimental and Clinical Medicine, DENOTHE Centre, University of Florence, Florence, Italy.
  • Rambaldi A; GenOMec, University of Siena, Siena, Italy.
  • Passamonti F; Centro Ricerca e Innovazione delle Malattie Mieloproliferative (CRIMM), Azienda Ospedaliera-Universitaria Careggi, Firenze, Italy.
  • Barosi G; Department of Experimental and Clinical Medicine, DENOTHE Centre, University of Florence, Florence, Italy.
  • Barbui T; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Cazzola M; Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
  • Vannucchi AM; Centro Ricerca e Innovazione delle Malattie Mieloproliferative (CRIMM), Azienda Ospedaliera-Universitaria Careggi, Firenze, Italy.
Blood ; 129(24): 3227-3236, 2017 06 15.
Article en En | MEDLINE | ID: mdl-28351937

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mielofibrosis Primaria / Mutación Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2017 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mielofibrosis Primaria / Mutación Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2017 Tipo del documento: Article País de afiliación: Italia